← SynDRA
GAVESTINEL
SynDRA canonical compound SYN0002324 — structure-anchored drug synonym record
Clinical phase
Phase 3
Primary target(s)
GLRB | GRIN1 | GRIN2A | GRIN2B | GRIN2C | GRIN2D | GRIN3A | GRIN3B
Mechanism of action
glutamate receptor antagonist
All known targets
GLRB
GLRA1
GLRA2
GLRA3
GLRA4
GRIN1
GRIN2A
GRIN2B
GRIN2C
GRIN2D
GRIN3A
GRIN3B
Mechanisms of action (all sources)
glutamate receptor antagonist
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
ABCB11
GPR17
ALB
ALDH1A1
ALOX12
ALOX15
ALOX15B
CYP3A4
HDAC6
HPGD
HSD17B10
KDM4E
MAPT
TSHR
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
LOX15
Cross-references
PubChem CID:
6450546
ChEMBL:
CHEMBL44793
DrugBank:
DB06741
ChEBI:
92867
KEGG:
D04308
Wikipedia:
Gavestinel
TTD: D0O6AQ
Synonyms
GV-150526X
GV-150,526A
GV-150526
GV150526
UNII-318X4QY113
318X4QY113
1H-Indole-2-carboxylic acid, 4,6-dichloro-3-(3-oxo-3-(phenylamino)-1-propenyl)-, (E)-
4,6-Dichloro-3-((E)-2-(phenylcarbamoyl)vinyl)indole-2-carboxylic acid
1H-Indole-2-carboxylic acid, 4,6-dichloro-3-((1E)-3-oxo-3-(phenylamino)-1-propenyl)-
(E)-4,6-Dichloro-3-(3-oxo-3-(phenylamino)-1-propenyl)-1H-indole-2-carboxylic acid
GV 150526
Gavestinel (USAN/INN)
AC1O51WR
Gavestinel [USAN:INN:BAN]
CHEMBL44793
SCHEMBL678632
SCHEMBL1721070
gavestinelum
RefChem:639773
DTXCID40200805
GAVESTINEL [INN]
GAVESTINEL [USAN]
GAVESTINEL [MART.]
SCHEMBL30184856
CHEBI:92867
WZBNEZWCNKUOSM-VOTSOKGWSA-N
BDBM50010475
DA-63712
MS-33148
HY-150138
CS-0612182
NS00069212
D04308
BRD-K49890030-236-01-6
BRD-K81981783-236-01-1
BRD-K81981783-236-02-9
AKOS024457063
GLXC-04126
DB-221849
Look up GAVESTINEL in the interactive SynDRA portal →